Acide déhydrocholique

Acide déhydrocholique may be available in the countries listed below.

Ingredient matches for Acide déhydrocholique

Dehydrocholic Acid

Acide déhydrocholique (DCF) is known as Dehydrocholic Acid in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Salvitos

Salvitos may be available in the countries listed below.

Ingredient matches for Salvitos

Methylcellulose

Methylcellulose is reported as an ingredient of Salvitos in the following countries:

• Argentina

International Drug Name Search

Olanzapine Tablets

Pronunciation: oh-LAN-za-peen
Generic Name: Olanzapine
Brand Name: Zyprexa

Olanzapine is an antipsychotic. It may increase the risk of death when used to treat mental problems caused by dementia in elderly patients. Most of the deaths were linked to heart problems or infection. Olanzapine is not approved to treat mental problems caused by dementia.

Olanzapine is used for:

Treating schizophrenia or bipolar disorder. It is also used along with another medicine (fluoxetine) to treat certain types of depression. It may also be used for other conditions as determined by your doctor.

Olanzapine is an atypical antipsychotic. Exactly how it works is not known. It is thought to affect certain substances in the brain.

Do NOT use Olanzapine if:

• you are allergic to any ingredient in Olanzapine

Contact your doctor or health care provider right away if any of these apply to you.

Video: Treatment for Depression

Treatments for depression are getting better everyday and there are things you can start doing right away.

Before using Olanzapine:

Some medical conditions may interact with Olanzapine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of seizures, heart problems (eg, heart failure; fast, slow, or irregular heartbeat), an abnormal electrocardiogram (ECG), a heart attack, a stroke or "mini-stroke," blood vessel problems, high blood cholesterol levels, high or low blood pressure, or low white blood cell levels


• if you have a history of liver problems, stomach or bowel problems (eg, decreased muscle movement), enlarged prostate, narrow-angle glaucoma, neuroleptic malignant syndrome (NMS), aspiration pneumonia, or suicidal thoughts or attempts


• if you have Alzheimer disease, bowel blockage, dementia, or trouble swallowing


• if you have diabetes or are very overweight, or if a family member has had diabetes


• if you have had high blood prolactin levels or a history of certain types of cancer (eg, breast, pancreas, pituitary), or if you are at risk of breast cancer


• if you are dehydrated or have low blood volume, drink alcohol, smoke, or you will be exposed to high temperatures

Some MEDICINES MAY INTERACT with Olanzapine. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Tramadol because the risk of seizures may be increased


• Alpha-blockers (eg, doxazosin), diazepam, or medicines for high blood pressure because the risk of low blood pressure and fainting may be increased


• Anticholinergics (eg, scopolamine), benzodiazepines (eg, lorazepam), or fluvoxamine because they may increase the risk of Olanzapine's side effects


• Carbamazepine, HIV protease inhibitors (eg, ritonavir), omeprazole, or rifampin because they may decrease Olanzapine's effectiveness


• Dopamine receptor agonists (eg, pramipexole) or levodopa because their effectiveness may be decreased by Olanzapine

This may not be a complete list of all interactions that may occur. Ask your health care provider if Olanzapine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Olanzapine:

Use Olanzapine as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Olanzapine comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Olanzapine refilled.


• Take Olanzapine by mouth with or without food.


• Drinking extra fluids while you are taking Olanzapine is recommended. Check with your doctor for instructions.


• Continue to take Olanzapine even if you feel well. Do not miss any doses.


• If you miss a dose of Olanzapine, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Olanzapine.

Important safety information:

• Olanzapine may cause dizziness, drowsiness, or decreased vision. These effects may be worse if you take it with alcohol or certain medicines. Use Olanzapine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol while you are taking Olanzapine.


• Talk with your doctor before you use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are taking Olanzapine; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Olanzapine may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Do not suddenly stop taking Olanzapine without checking with your doctor.


• Do not become overheated or dehydrated in hot weather or while you are being active; heatstroke may occur.


• If vomiting or diarrhea occurs, you will need to take care not to become dehydrated. Contact your doctor right away if you think you may be dehydrated.


• Olanzapine may raise your blood sugar. High blood sugar may make you feel confused, drowsy, or thirsty. It can also make you flush, breathe faster, or have a fruit-like breath odor. If these symptoms occur, tell your doctor right away.


• Olanzapine may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• NMS is a possibly fatal syndrome that can be caused by Olanzapine. Symptoms may include fever; stiff muscles; confusion; abnormal thinking; fast or irregular heartbeat; and sweating. Contact your doctor at once if you have any of these symptoms.


• Some patients who take Olanzapine may develop muscle movements that they cannot control. This is more likely to happen in elderly patients, especially women. The chance that this will happen or that it will become permanent is greater in those who take Olanzapine in higher doses or for a long time. Muscle problems may also occur after short-term treatment with low doses. Tell your doctor at once if you have muscle problems with your arms; legs; or your tongue, face, mouth, or jaw (eg, tongue sticking out, puffing of cheeks, mouth puckering, chewing movements) while taking Olanzapine.


• Some patients have experienced weight gain while using Olanzapine. You may need to have regular weight checks while you use Olanzapine.


• Lab tests, including fasting blood glucose, cholesterol, complete blood cell counts, and liver function, may be performed while you take Olanzapine. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Olanzapine with caution in the ELDERLY; they may be more sensitive to its effects, especially uncontrolled muscle movements.


• Caution is advised when using Olanzapine in CHILDREN; they may be more sensitive to its effects, especially drowsiness, increased cholesterol and lipid levels, increased levels of prolactin (a hormone), and weight gain. Children may need regular weight checks while they take Olanzapine.


• Olanzapine should be used with extreme caution in CHILDREN younger than 13 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Olanzapine while you are pregnant. Taking Olanzapine during the third trimester may result in uncontrolled muscle movements or withdrawal symptoms in the newborn. Discuss any questions or concerns with your doctor. Olanzapine is found in breast milk. Do not breast-feed while taking Olanzapine.

Possible side effects of Olanzapine:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Back or joint pain; constipation; cough; dizziness; drowsiness; dry mouth; increased appetite; indigestion; lightheadedness; numbness or tingling of the skin; restlessness; sore throat; weakness; weight gain.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); abnormal thoughts; chest pain; confusion; decreased urination; fainting; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; increased saliva production or drooling; increased sweating; memory loss; menstrual changes; muscle pain, weakness, or stiffness; new or worsening mental or mood changes (eg, depression, hallucinations); one-sided weakness; seizures; severe or prolonged dizziness or headache; shortness of breath; suicidal thoughts or actions; swelling of the hands, legs, or feet; symptoms of high blood sugar (eg, increased thirst, hunger, or urination; unusual weakness); symptoms of high prolactin levels (eg, enlarged breast size, decreased sexual ability, missed menstrual period, nipple discharge); tremor; trouble concentrating, speaking, or swallowing; trouble sitting still; trouble walking or standing; uncontrolled muscle movements (eg, arm or leg movements, jerking or twisting, twitching of the face or tongue); unusual bruising; vision changes; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Olanzapine side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include abnormal thinking; aggression; agitation; chest pain; coma; confusion; difficult or slurred speech; fainting; fast or irregular heartbeat; fever; mental or mood changes; seizure; severe drowsiness, dizziness, or weakness; severe or persistent headache; slow or shallow breathing; stiff muscles; sweating; uncontrolled muscle movements.

Proper storage of Olanzapine:

Store Olanzapine at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Keep Olanzapine out of the reach of children and away from pets.

General information:

• If you have any questions about Olanzapine, please talk with your doctor, pharmacist, or other health care provider.


• Olanzapine is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Olanzapine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Olanzapine resources

• Olanzapine Side Effects (in more detail)
• Olanzapine Dosage
• Olanzapine Use in Pregnancy & Breastfeeding
• Drug Images
• Olanzapine Drug Interactions
• Olanzapine Support Group
• 90 Reviews for Olanzapine - Add your own review/rating

Compare Olanzapine with other medications

• Agitation
• Anorexia
• Asperger Syndrome
• Bipolar Disorder
• Body Dysmorphic Disorder
• Borderline Personality Disorder
• Depression
• Insomnia
• Obsessive Compulsive Disorder
• Paranoid Disorder
• Schizoaffective Disorder
• Schizophrenia
• Tourette's Syndrome

Daptomycin

In the US, Daptomycin (daptomycin systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Endocarditis, Methicillin-Resistant Staphylococcus Aureus Infection, Skin and Structure Infection and Skin Infection.

US matches:

• Daptomycin


• Daptomycin Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01XX09

CAS registry number (Chemical Abstracts Service)

0103060-53-3

Chemical Formula

C72-H101-N17-O26

Molecular Weight

1620

Therapeutic Category

Antibacterial

Chemical Names

N-(1-Oxodecyl)-L-tryptophyl-Lasparaginyl-L-alfa-aspartyl-L-threonylglycyl-L-ornithyl-L-alfa-aspartyl-D-alanyl-L-alfa-aspartylglycyl-D-seryl-threo-3-methyl-L-alfa-glutamyl-gamma-(2-amminophenyl)-gamma-oxo-L-alfa-aminobutanoic acid epsilon1-lactone

N-decanoyl-L-tryptophyl-L-asparaginyl-Laspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine,1.13-3.4-lactone (BAN)

N-decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine,epsilon1-lacton (IUPAC)

N-Decanoyl-L-tryptophyl-L-asparaginyl-L-aspartyl-L-threonylglycyl-L-ornithyl-L-aspartyl-D-alanyl-L-aspartylglycyl-D-seryl-threo-3-methyl-L-glutamyl-3-anthraniloyl-L-alanine,epsilon1-lactone (WHO)

Foreign Names

• Daptomycinum (Latin)
• Daptomycin (German)
• Daptomycine (French)
• Daptomicina (Spanish)

Generic Names

• Daptomycin (OS: USAN, BAN)
• LY-146032 (IS: Lilly)

Brand Names

• Cubicin
  Chiron, Luxembourg; Chiron, Netherlands; Cubist, Taiwan; Cubist, United States; Novartis, Australia; Novartis, Switzerland; Novartis, Germany; Novartis, Spain; Novartis, Finland; Novartis, France; Novartis, United Kingdom; Novartis, Croatia (Hrvatska); Novartis, Italy; Novartis, Norway; Novartis, Portugal; Novartis, Sweden; Novartis, Slovenia; Novartis Europharm, Austria; Novartis Europharm Ltd., Denmark; Oryx, Canada; TTY Biopharm, Taiwan

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Azatyl

Azatyl may be available in the countries listed below.

Ingredient matches for Azatyl

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Azatyl in the following countries:

• Greece

International Drug Name Search

Virfen

Virfen may be available in the countries listed below.

Ingredient matches for Virfen

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Virfen in the following countries:

• Greece

International Drug Name Search

Charcoal

In the US, Charcoal (charcoal/simethicone systemic) is a member of the following drug classes: antidotes, miscellaneous GI agents and is used to treat Gas and Gastrointestinal Decontamination.

US matches:

• Charcoal


• Charcoal Activated


• Charcoal Plus DS


• Charcoal, activated

Ingredient matches for Charcoal

Charcoal

Charcoal, Activated is reported as an ingredient of Charcoal in the following countries:

• New Zealand


• United States

International Drug Name Search

Eifilins

Eifilins may be available in the countries listed below.

Ingredient matches for Eifilins

Aminophylline

Aminophylline is reported as an ingredient of Eifilins in the following countries:

• Lithuania

International Drug Name Search

Carvisken

Carvisken may be available in the countries listed below.

Ingredient matches for Carvisken

Pindolol

Pindolol is reported as an ingredient of Carvisken in the following countries:

• Japan

International Drug Name Search

Baclofen PCH

Baclofen PCH may be available in the countries listed below.

Ingredient matches for Baclofen PCH

Baclofen

Baclofen is reported as an ingredient of Baclofen PCH in the following countries:

• Netherlands

International Drug Name Search

Déflazacort

Déflazacort may be available in the countries listed below.

Ingredient matches for Déflazacort

Deflazacort

Déflazacort (DCF) is also known as Deflazacort (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Chlooramfenicol POS

Chlooramfenicol POS may be available in the countries listed below.

Ingredient matches for Chlooramfenicol POS

Chloramphenicol

Chloramphenicol is reported as an ingredient of Chlooramfenicol POS in the following countries:

• Netherlands

International Drug Name Search